Inositec is a biotech company that develops a treatment for soft tissue calcification disorders.
Inositec is tracked in the Tech.eu funding database. Based in Zurich, Switzerland; active in Healthtech. Acquired by Vifor Pharma in 2021. Data as of 5 Oct 2026.
